Puma Biotechnology (PBYI) Other Operating Expenses (2017 - 2025)
Historic Other Operating Expenses for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $12.2 million.
- Puma Biotechnology's Other Operating Expenses fell 5816.41% to $12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.0 million, marking a year-over-year decrease of 3456.27%. This contributed to the annual value of $64.4 million for FY2024, which is 274.72% up from last year.
- Latest data reveals that Puma Biotechnology reported Other Operating Expenses of $12.2 million as of Q3 2025, which was down 5816.41% from $12.3 million recorded in Q2 2025.
- Puma Biotechnology's Other Operating Expenses' 5-year high stood at $29.6 million during Q1 2021, with a 5-year trough of $10.3 million in Q3 2021.
- Moreover, its 5-year median value for Other Operating Expenses was $12.3 million (2025), whereas its average is $15.2 million.
- In the last 5 years, Puma Biotechnology's Other Operating Expenses surged by 22566.11% in 2021 and then plummeted by 6331.16% in 2022.
- Puma Biotechnology's Other Operating Expenses (Quarter) stood at $11.9 million in 2021, then surged by 41.54% to $16.8 million in 2022, then surged by 44.47% to $24.3 million in 2023, then tumbled by 42.77% to $13.9 million in 2024, then decreased by 12.56% to $12.2 million in 2025.
- Its last three reported values are $12.2 million in Q3 2025, $12.3 million for Q2 2025, and $10.6 million during Q1 2025.